|
Real-time Estimate
Cboe BZX
20:39:23 24/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 23.85 USD | -4.29% |
|
-2.18% | +44.28% |
| 03:19pm | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
| 08-07 | UBS Adjusts Price Target on Denali Therapeutics to $34 From $25, Maintains Buy Rating | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
DNLI 23.82 $
-4.41%
16.77M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| DNLI | 23.82USD | -4.41% | 16.77M $ | |
CBOE
| DNLI | 23.83USD | -4.37% | 324K $ | |
|
Boerse Muenchen
| 4DN | 20.48EUR | -3.80% | 8.83K € | |
|
Tradegate
| 4DN | 21.56EUR | +1.08% | 1.01K € | |
|
Deutsche Boerse AG
| 4DN | 21.04EUR | -0.47% | 0 € | |
|
Börse Stuttgart
| 4DN | 21.48EUR | +0.85% | 0 € | |
Sao Paulo
| D2NL34 | 27.06BRL | -1.31% | 54.12 R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 27.21 | 27.21 | 25.83 |
| Spread/Res. | -12.46% | -12.46% | -7.78% |
| Spread/Supp. | +8.62% | +8.62% | +30.16% |
| Support | 21.93 | 21.93 | 18.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DNLI Stock
- Charts Denali Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
